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While  the occurrence  of autoimmunity in ulcerative colitis is now well established 
(see  1 of Bibiography), its cause is not yet understood. In most patients the serum 
contains anti-colon antibodies which react with a heat-stable gastrointestinal antigen 
of human and animal origin, chemically related to but immunologically  distinct from 
the blood group (ABH) substances (2--4). The antibodies axe autoantibodies (5, 6). 
There is evidence that the elevated anti-colon antibody titer in human ulcerative 
colitis is not merely the result of chronic colon damage. Thus, antibody titers are low 
or nonexistent in the sera of patients with unrelated gastrointestinal diseases,  even 
when accompanied by severe colon damage (7). Furthermore, antibody titers are not 
related to clinical  status of the patients, duration of the disease  and other clinical 
variables (5-7). 
Autoantibodies can be produced in experimental animals by breakage of natural 
tolerance by the injection of cross-reacting  antigens (8, 9). This has also been achieved 
in the ease of the colon by injecting rabbits with rat colon (10) or rats with newborn 
rabbit colon (11). These studies have provided conclusive evidence of an immunological 
relationship  between antigen  from germ-free gastrointestinal  mucins  and bacterial 
antigens.  These latter findings are important since they may explain the induction of 
autoantibody formation in ulcerative colitis as well. Such a mechanism has previously 
been suggested  for the production of autoimmRnity  in other human diseases,  where 
cross-reactions  between bacteria and the organs involved have been seen (12, 13). 
In the search for bacterial antigens cross-reacting with colon antigen, we have 
concentrated our efforts on Escherichiacol$ O14 which contains an active form 
of a heterogenetic antigen common for most Enteroba~:teriaceae (14-16). Earlier 
results with sera from patients, as well as with rats made autoimmune by inject- 
ing them with rabbit colon (3, 11) suggested that immunologically active struc- 
tures  in  common for E.  coli O14  and  colon  do  exist.  In this  paper,  further 
evidence  for  this  cross  reactivity  and  for  the  possible  significance  of  the 
beterogenetic antigen for the  induction of  anti-colon antibodies in ulcerative 
colitis will be presented. 
* This work was supported by Grant-B69-16X-159 from the Swedish Medicine Research 
Council. 
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Mcaerial  and Methods 
Antigen was extracted from sterile rat colon and from bacteria by phenol-water at 65°C  as 
earlier described (17).  Colon antigen was obtained either from pooled homogenates of germ- 
free rat colon and cecum, or from dried feces. It contains human blood group A and H activity 
but no B  activity. (4,  18). The rats were of a Swedish inbred strain,  reared under germ-free 
conditions for 18 generations and raised on the semisynthetic diet D7  (19, 20). E. coli strains 
were  obtained from  the  International Escherichia  coli  Center in  Copenhagen through the 
courtesy of Dr. F. 0rskov and from the University of Gothenburg through the courtesy of Dr. 
K. Lincoln. The bacteria were grown for 18 hr at 37°C on a synthetic substrate containing 
sodium lactate as the carbon source (11). Clostridium  cliff,  tile isolated from normal rat feces 
was grown anaerobically for 72 hr at 37°C on Dffco Bacto Fluid thiogiycolate medium (Difco 
Laboratories, Detroit, Mich.), and Staphylococcus aureus S 209 (from the Karolinska Hospital, 
Stockholm) for 18 hr at 370C  on a  dialysate of Trypticase soy broth (Difco Laboratories, 
Detroit, Mich.). All bacteria were grown in liquid culture, collected by centrifugation, washed 
in physiological saline, and heat inactivated. Clostridium  diffwile was killed with 0.5% form- 
aldehyde before extraction. None of the bacterial strains used contained measurable blood 
group A or H  activity, as assessed by hemagglutination inhibition experiments with human or 
eel serum and human erythrocytes. 
Sera Were collected from randomly selected patients with clinically, rectoscopically, and 
roentgenologically typical ulcerative colitis.  The  sera were  obtained  from  the  Karolinska 
Hospital and St. Erik's Hospital, Stockholm (7). Control subjects were sex- and age-matched 
healthy blood donors and laboratory personnel from Sweden. A second control group consisted 
of South African patients with amebic dysentery or with liver abscess, and healthy individuals 
from the same territory. The South African sera were kindly supplied by Dr. S. E. Maddison, 
Amoebiasis Research Unit, ])urban, South Africa. Sera were collected aseptically, heat inac- 
tivated at 56°C, divided into small aliquots, and kept at --20°C until titrated. Prior to testing, 
all  sera  were absorbed with sheep erythrocytes  and human AI erythrocytes  (7). 
The technique of p~sive hemagglutination  was the same as that used earlier (4, 7). In each 
titration series, sera from the same five patients with ulcerative colitis and from five blood- 
donors were incorporated to assess the reproducibility of the test. The titrations were repro- 
ducible within 4-1 dilution steps (7). For sensitization of 0.025 ml packed red cells the follow- 
ing antigen concentrations were used:  colon 2.0 mg/ml; E. co/i O14, 0.03 mg/ml; E. ¢oli 07, 
0.064 mg/ml; E. coli 06,  0.25  mg/ml; E.  coli  08, 0.05  mg/ml; E.  co/i 075, 0.25  mg/ml; 
Closfi,  idium diffu:ile, 0.5 mg/ml; Staphylococcus aureus S 209, 2.0 mg/ml. These concentrations 
gave optimal sensitization of red cells when tested with a  few standard ulcerative colitis 
sera. Sensitization with colon antigen was slightly suboptimal (3). Bacterial  agglutination  of 
heat-killed E. coli,  grown  in Petri dishes on  brain veal  agar for 18  hr, was performed by 
Dr.  K.  Lincoln. 
For hemagglutination  inhibition tests, sera with a titer of >  1/32 were chosen. Tests were 
performed in two ways.  (a) For sereening of a large number of sera; to each twofold dilution 
of serum inhibitor was added at a constant concentration (usually 2.0 mg/ml). After incuba- 
tion for ~  hr at room temperature the cells were added and hemagglutination was recorded 
as usual (4). The titers were compared with those obtained in titrations of aliquots of the same 
sera, properly diluted with saline. A titer reduction by at least three dilution steps was regarded 
as indicative of cross-reactivity (3). (b) To 0.1 ml aliquots of the sera, diluted to contain four 
to eight hemaggiutinating units (HU) of antibody, varying concentrations (2-2000/~g/ml) 
of inhibiting antigen were added,  as earlier described  (4,  11). 
E. con O14 for immunization  of rabbits  were  grown  as  already  described,  collected  by 
centrifugation, washed in physiological saline, and killed by treatment with 0.5~ formalin 
for 2  days at 37°C. After dialysis against distilled water, the suspension was concentrated. LAGERCILANTZ,  HAMMARSTROM, PERLMAN, AND GUSTA~'SSON  1341 
1 ml containing  1 mg bacteria  (dry weight) was mixed with  1 ml of Freund's incomplete 
adjuvant and injected intramuscularly.  Two injections were given 14 days apart and aati- 
serum  was collected 7 days after  the last  injection. 
RESULTS 
Antibodies to Rat Colon in Sera from Patients with Ulcerative  Colitis and Con- 
trols.--Titers in patients with ulcerative colitis and the various control groups 
are given in Table I. Mean titer height and incidence of elevated titers in the 
ulcerative colitis group are significantly increased over the controls. The differ- 
TABLE I 
Distribution of Hemagglutinating Titers to Rat Colon Antigen in  Ulcerative Colitis Patients 
and Different Categories of Controls 
Origin  of 
~ra 
Sweden 
South 
Africa 
Clinical group 
Ulcerative colitis 
(white) 
Healthy (white) 
Amoebic dysentery 
(colored) 
Amoebic liver abscess 
(colored) 
Healthy (colored) 
"  (Asian) 
"  (white) 
No. 
of 
~r8 
24--  .-- 
33 
29 
16 
108 
106 
111 
No. of ~rareacfingathighest 
dilution of 
1/2  i/4 
1  10 
1  5 
1  2 
3  22 
2  20 
5  41 
11811116 
! 
1  5 
18  3 
13  5 
i 
4[4 
29  20 
32  21 
29  26 
1/321/64  ~  ~  .~  ~. 
8  4  51--.~  1 
1 
2  3 
5 
19  8  4  3 
_  11  15  5 
5  5 
Mean 
titer 
2  5.8. 
2 9. .8 
2 3 .4 
2  s  ,6 
2  8.7 
28.s 
2  s .t 
Sel~ 
with 
titer 
>l/z: 
% 
75 
3 
17 
31 
31 
29 
9 
* The superscripts  represent  the mean values of the number of dilution  steps  at which 
end point was reached. 
ence between patients with ulcerative colitis and controls either from Sweden 
or from South Africa is highly significant (x  2 =  27, P  <  0.01). Patients with 
ameba  dysentery  or  ameba  liver  abscess  do  not  differ  from  their  controls 
(colored or Asian blood donors from the same territory) who also have elevated 
titers  more often than  South African whites.  The difference between  on one 
hand, healthy colored and Asian and, on the other, white South Africans is also 
significant (x  ~ =  9, P  <  0.01). 
Antibiodies  to E. Coli 014 in Sera from Patients with  Ulcerative  Colitis and 
Controls.--The optimal sensitizing dose of E. coli O14 antigen was the same for 
four high-fitered ulcerative colitis sera (0.03 mg/ml). Lower as well as higher 
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With  this dose,  sera of ulcerative colitis patients  and controls were investi- 
gated. In three independent experiments, mean titers and incidence of elevated 
fiters  (> 1/128)  against E. coli O14 were  significantly increased  in ulcerative 
colitis  as compared  to  the  controls.  Typical  results  from one  experiment  are 
shown  in  Table  II.  The  difference  between  patients  and  controls  is  highly 
significant (X  2 =  16.5, P  <  0.01). 
Independent confirmation of these data was obtained by Dr. K. Lincoln who 
tested a randomly selected group of our sera from ulcerative colitis patients and 
Swedish controls both in passive hemagglutination  and in bacterial  agglutina- 
tion.  In  the  hemagglufinafion  experiment,  sheep cells  were  sensitized  with  a 
TABLE II 
Anlibodle~ to E. coU 0:14 in Ulcerative Colitis Patienls and Different Categories of Controls 
Origin of 
8erK 
Sweden 
South 
Mrica 
Clinical group 
Ulcerative colitis 
(white) 
Healthy (white) 
Amoebic dysentery 
(colored) 
Amoebic liver abscess 
(colored) 
i  i Healthy (colored) 
No. 
of 
$era 
32 --  -- 
No. of sere  reacting at highest 
dilution of 
32 -- 
28 
16 
19 
1/2  1/4 
--  4 
--  1 
--  2 
'qs !1115 
1  2 
i 
4  11 
I 
i 
6  7 
3  5 
4  6 
tmi/64 ~  ~  ~  ,  ~  -~,~  ~ 
] 
6  8  6il  4  4 
I 
8  7  2  .... 
6  3  --  2 
I 
1  4  2] .... 
2  3  --  2 
t/ter 
2 6 .7* 
24.7 
24.2 
2 4.e 
24.2 
Sera 
with 
titer 
< 1/I~ 
% 
47 
6 
7 
13 
11 
* See Table I. 
saline extract of heat-killed E. coli O14.7 of 21 sera from patients with ulcerative 
colitis had titers of 1/16 or more, but only 1 of 22 controls (difference statisti- 
caUy significant,  x 2 =  4.1, P  <  0.01).  In bacterial agglutination  of heat-killed 
organisms,  9  of 22 patients and 2 of 22 controls had  a  titer of >  1/32  (x  2 = 
4.3, P  <  0.01). 
Antibodies to E. coli 014 and Clinical Variables.--To investigate the hypoth- 
esis that elevated titers  against E. coli 014  are caused by intensified  bacterial 
stimulation  through  the  ulcerated  colon mucosa,  antibody  titers  and  clinical 
variables were compared. The clinical variables were the same as those recorded 
earlier  (7). In sera from 27 unselected  ulcerative colitis patients  there was no 
relation  between antibody  titer  to E. coli  O14  and duration or severity  of the 
disease,  extent  of colon involvement,  or presence of extra colonic manifestations. 
Antibodies to Other E. coli, Staphylococcus  aureus S  209,  Clostridium Diff~ile 
and Sheep Red Cells  (Forsman Antigen) in Ulcerative Colitis and Swedish Con- LAGERCRANTZ, HA~rANSTROM,  PERLM.AN, AND  GUSTA.FSSON  1343 
trols.--Aliquots  of the same ulcerative colitis sera  and Swedish controls (32 
unselected sera in each group) were also titrated against sheep cells sensitized 
with E. coli 07, E. coli 075, E. coli 06, and Staphylococcus  aureus S 209. Opti- 
mal sensitization doses were determined with the same four ulcerative colitis 
sera as used in the experiments  described  above. All four sera  gave  optimal 
sensitization at the  same concentration when tested with the same antigen. 
However, the optimal concentrations were different for the three antigens (see 
Materials and Methods). Fig. I shows the incidence of antibody titers > 1/64 to 
the four bacterial antigens. For comparison, the incidence of anti E. coli O14 
titers in the same group of sera, as obtained in the experiment of Table II, is 
also included. No difference between ulcerative colitis and controls was seen 
when these sera were tested with E. coli 075, E. coli 07, or with St. aureus S 
% 
75 
5O 
25 
l~nlibody  E.Coll  EColi  E.Coli  E.C~i  3taph. 
~oinst  0.14  Q75  0.7  G6  oureus 
FIG. 1. Percentages  of elevated fiters (;~ 1/64) to different strains of E. coli and to Staphy- 
lococcus aureus in patients with ulcerative colitis (black bars) and matched controls (white 
bars). 
209. With E. coli 06  the difference between the groups  was not  significant. 
Comparison of mean titers gave similar results. (Thus, for the patients, mean 
titers to E. coli O14, 075, 06, 07, and Staph. aureus were 26.~, 28.8 2  e.*, 2  s, and 
24.8 respectively. For the controls these means were 2  *-6, 29,  2  r, 28.6, and 2  *.9 
respectively.) 
Further studies on the  antibody pattern in ulcerative colitis and controls 
revealed that they were not significantly different when tested with extracts of 
a member of the anaerobic gut flora, Clostridium diff~ile. 23 of 30 of the ulcera- 
tive colitis group and 18 of 29 controls had titers > 1/128. The mean titers for 
the two groups were 2  ~'s and 2 ~.8, respectively. When titrated with unsensitized 
sheep erythrocytes (sera not absorbed with sheep erythrocytes), 2 of 32 ulcera- 
tive colitis sera and 2 of 29 controls had anti-Forsman antibody titers of >  1/128 
(Mean titers 23a and 2  a,6, respectively). 
Cross-reaction  between E. coli 014 and Rat Colon  Antigen.--Absorption  with 
E. coli O14 antigen inhibited the reaction between colon sensitized sheep cells, 
and sera from ulcerative colitis patients in approximately one-third of the large 1344  rM'~UNOLOGICAL STUDIES IN ULCERATIVE COLITIS.  IV 
number  of sera  tested  (Table  III).  Using  this  rather  insensitive  method,  no 
inhibition was found with E. coli 07 or E. coli 075. In the reverse experiment 
(E.  coli  O14 antigen  as sensitizer  and  colon antigen  as inhibitor),  significant 
inhibition was demonstrated in only 2 of 16 ulcerative colitis sera. 
TABLE HI 
Hemagglulination  Inhibition Experiment with  Ulcerative Colitis  Sera and Antigen from Germ- 
Free Rat Colon or E. coli 
Sensitizing antigen 
Rat colon 
E. coli O:14 
Rat colon 
44/44* 
2116 
Inhibiting  antigen 
E. aoli 0:14 
13/44 
16/16 
F.. call 0:7 
0/40 
E. cdl 0:75 
0/40 
* No. of patients' sera showing titer reduction of >3 dilution steps following absorption 
with 2.0 mg/ml of inhibiting antigen (see Material  and Methods).  Data based on 44 ulcera- 
tive colitis sera with hemagglutination  titers  against colon > 1/16.  16 of these have anti-g. 
coli O14-titers  > 1/16. 
Not done. 
TABLE IV 
Hemagglutination-Inhibition  Assay for Cross-Reactivity  of Anticolon Antibodies  in  Ulcerative 
Colitis Sara with Bacterial  Antigens. Erythrocytes  Sensitized  with Germ-Free 
Rat Colon Antigen 
Antigen needed for complete inhibition of 4 
Inhibitor  hemagglutinating  units of ulcerative colitis serum* 
Germ-free rat colon 
E. coli 0:14 
"  O:1 
"  0:2 
"  0:3 
"  0:7 (0:39) 
"  0:8 
"  0:9 
"  O:18 
"  O:75 
uc/ml 
8 
64 
1000 
>1000 
1000 
1000 
1000 
>1000 
1000 
>1000 
* The anti-colon titer of this serum was 1/128. Inhibition experiments performed in dupli- 
cates.  >  : No inhibition at highest doses tested. 
Since the number of sufficiently high-titered  (anticolon)  control sera  (both 
Swedish and South African) was limited, no conclusive results were obtained in 
absorption experiments of this type. 
Table  IV  summarizes  a  typical hemagglutination inhibition  experiment,  in 
which varying concentrations of different antigens were added to four HU of a LAGERCRANTZ, H.AMMARSTROM, PEI~LMAN, AND GUSTA:FSSON  1345 
high-titered ulcerative colitis serum, run against colon sensitized sheep erythro- 
cytes. Of the bacterial extracts tested E. coli O14 was by far the strongest 
inhibitor. Of the others, only E. coli 03, 07 (039), and 08 also gave weak inhibi- 
tion when added at approximately 100 times the concentration of the homol- 
ogous inhibitor. In all, 30 different sera from ulcerative colitis  patients have 
been tested in this way, all with similar results. No hemagglutination  inhibition 
was  demonstrated with phenol-water  extract  of  pneumococci  or  hemolytic 
streptococci. 
65,568 
16,392 
4,096 
i  1,024 
256 
641 
16 
0.5  2  8  32  125  500  2000 
gg~nl d  aotigen  for sensitization of 0.025ml packed sheep  ted cells 
Fro. 2.  Hemagglutination with rabbit anti-E, co]i O14 serum of sheep red blood cells sensi- 
tized with different concentrations of antigen from  four different strains of E. coli. liB, E. co]i 
O14; O, E. coli O1; A, E. coli 08; A, E. coil 075. (For further explanations see Material 
and Methods.) 
Rdationship of the Rat Colon Antigen to the Heterogenetic Antigen of Entero- 
bacteriaceae.--The  relationship between rat colon antigen and the common anti- 
gen of Enterobacteriaceae was also tested with rabbit anti-E, coli 014  sera. 
Such sera usually contain antibodies to the type-specific somatic antigen (014) 
in high concentration. Therefore the assay for the common antigen requires 
that the red blood cells be sensitized with antigen from another strain, whose 
somatic antigen is unrelated to that of E. coli 014 (14-16). It is also necessary 
to choose a strain with a relatively high activity of the common antigen, since, 
otherwise,  the titer may be determined by the animal's natural antibodies to 
the specific somatic antigen of the sensitizing strain. The activity of the com- 
mon antigen in other strains than E. coli 014 can be determined by measuring 1346  IMMUNOLOGICAL  STUDIES  IN  ULCERATIVE  COLITIS.  IV 
the optimal sensitizing dose for hemagglutination with anti-014 serum.  Of the 
E.  coli antigens  available for this investigation,  E.  coli  08  gave the  highest 
titer at relatively low doses when  tested with rabbit anti E.  coli O14  serum 
(Fig.  2).  It was therefore  chosen  for the  assay of the  heterogenetic  antigen 
when  it  was established  that  its somatic antigen  was  unrelated  to  the  type 
specific 014 antigen. 
TABLE V 
ttemagglutination  Inhibition  Assay  for  Cross-Reaaivity  between  the  Common  Antigen  of 
Enterobaaeria~eae  a~nd Antigen from Germ Free Rat Colon. Rabbit Anti-E. coU 
0:14 Serum Reaaed with Sheep Cells Sensitized with E. coli 0:8 
Inhibitor 
Germ-free rat colon 
E. coli 0:I 
"  0:4 
"  O:7 (0:39) 
"  0:8 
"  O:14 
"  0:75 
(purified) § 
Antigen needed for complete inhibition of hemagglutination 
Serum 1"  Serum 2~ 
Exp. 1  Exp. 2 
8 HU  8 HU  4 HU 
ttg/ml 
1000 
125 
125 
500 
125 
--7 
2 
1000 
ttg/ml 
1000 
250 
125 
250 
125 
--7 
4 
1000 
1000 
250 
--7 
--7 
--7 
64 
<2 
--7 
* Sensitizing dose: 0.064 ~tg/ml; antibody titer:  1/512. 
"  "  : 0.032 ~g/ml;  "  "  : 1/2048. 
§ Phenol-water extract further purified by precipitation with ethanol between 51 to 55% 
concentration. 
¶ Not done. 
The reaction between two rabbit antisera to E. coli O14 and antigen from E. 
coli 08 was inhibited by the colon antigen as shown in Table V. In these experi- 
ments, both the phenol-water extracted colon antigen and a  purified fraction 
thereof were added as inhibitors. As can be seen, while the inhibitory power of 
the original colon extract was weak, the purified preparation was four to eight 
times more active. When compared with the original extract this preparation 
was also approximately eight times more active in regard to colon antigen con- 
centration,  as  revealed  by  hemagglutination  inhibition  experiments  with 
patients' sera and colon sensitized red cells (unpublished experiments). How- 
ever, even the purified rat colon antigen was about 50 times less effective as 
inhibitor than the homologous E. coli O14 antigen (Table V). The Table also LAG~.RCRANTZ,  HAMMLARSTRO~, PERL~AN, AND GUSTAFSSON  1347 
demonstrates that different strains of E. coli contain different concentrations of 
the inhibitory antigen. It will be noted that E.  coli 075  is considerably less 
active than E. coli 07. 
In all, six rabbit anti-E, coli O14 sera were available for these experiments. 
Most of these reacted as shown in Table V. Such sera also had elevated fiters 
when tested with colon sensitized erythrocytes. When tested with E. coli O14 
sensitized erythrocytes, the reactions were usually not inhibited with colon or 
E. coli 08 antigen. In a few sera, however, the reaction with E. call O14 sensi- 
tized cells was also inhibited with colon and E. coli 08. This was the case in 
those sera in which the antibodies to the common antigen were of a similar or 
higher concentration than those to the type specific O14 antigen. One serum was 
also encountered with a titer to E. coli 08 which could be inhibited neither with 
colon nor with E. coli O14 but only with E. coli 08. These reactions were prob- 
ably due to antibodies to the type specific 08 antigen present already before 
immunization. Taken together, these data strongly support the supposition that 
the cross-reacting factor of the colon extract is very similar to the common 
antigen of the Enterobacteriaceae. 
DISCUSSION 
The sera in this investigation was obtained from unselected ulcerative colitis 
patients and controls, most of whom have not been reported previously. The 
general level of hemagglutinating antibody titers seen here was higher than that 
reported earlier because of minor technical modifications. However, the differ- 
ence in incidence of elevated titers and mean titers between patients and healthy 
Swedish controls was significant and very similar to that noted previously (7). 
These results differ from those recently reported by McGiven et al. (21) who 
found elevated hemagglutination titers equally distributed in 20 % of the sera 
from Australian patients as well as controls. The reason for this discrepancy is 
not understood, particularly since 24% of their ulcerative colitis sera but only 6% 
of  their  controls gave a  positive fluorescent antibody staining of rat  colon 
mucosa. The present data provide no clue as to the specificity of the antibodies 
in the various controls. However, since the rat colon antigen is immunologically 
heterogenous (11),  they may well be directed to other determinants than the 
antibodies in the patients' sera. This is also supported by previous findings, 
that no such background activity is seen in normal sera when the assays are 
performed with sterile human colon extract (2). 
Elevated anti-colon antibodies do not appear in the sera of patients with 
unrelated diseases of the gastrointestinal tract (5-7). Nevertheless, it seemed 
important to include some patients with severe and long-lasting colon lesions 
among the controls. We therefore obtained sera  from patients  with  amebic 
dysentery, a disease which has many clinical and pathological similarities with 
ulcerative  colitis. Neither Wright and Truelove  (5)  nor Harrison  (6)  could 1348  r~UNOLOGICAL  STUDIES  IN  ULCERATIVE  COLITIS.  IV 
detect anti-colon antibodies in these patients, when using the fluorescent anti- 
body techniques. In this study, these South African sera had similar mean titers 
and incidence of elevated titers as sera from healthy individuals from the same 
territory and of the same racial origin (Negroes and Asian). These values were 
all slightly higher than those typical for the Swedish controls. However, the 
group of healthy South Mrican whites which was also included did not differ 
from healthy Swedish controls. 
The possibility of autoimmunization in ulcerative colitis, arising from break- 
age of tolerance by cross-reacting bacterial antigen, was supported by earlier 
preliminary findings of an increased incidence of elevated titers to phenol-water 
extracted antigen from E. coli 014 in the patients' sera. In contrast, the spec- 
trum of antibodies to some common serotypes of E. coli  and Salmonella was 
found to be the same in patients and controls (3). This is important because E. 
coli O14 is known to carry a particularly immunogenic form of a heterogenetic 
antigen,  common  for  most  Enterobacteriaceae  (14-16,  22-24).  Significant 
amounts of this antigen must therefore always be present in the human intes- 
tine, even in the absence of E. coli 014. The data presented here confirm and 
extend previous findings. Evidence for increased incidence of anti-E,  coli  O14 
antibodies in ulcerative colitis has now been presented in a  second group of 
patients.  No deviations from the normal antibody pattern were observed in 
regard  to  antibodies to Forsman antigen, Staphylococcus  aureus,  Clostridium 
diff~cile, and E. coli 075. As noted for anti-colon titers (7),  anti-E, coli O14 
titers in ulcerative colitis patients were not related to the clinical state of the 
disease in individual patients.  Furthermore, the antibody pattern to E.  coli 
O14 in patients with amebic dysentery, whose colonic lesions are comparable 
in severity to those of ulcerative colitis, was indistinguishable from that of the 
healthy controls. 
Taken together, these data do not favor the notion that elevated antibody 
titers to colon and to E. coli O14 are sequelae of colon damage in general. Rather 
they suggest that these phenomena are in some way causally related. This is 
strongly supported by the results of hemagglutination inhibition experiments 
which prove that the phenol-water extracted antigen from germ free rat colon is 
immunologically  related to the antigen in a corresponding extract of E. coli O14. 
Thus, in about 30 % of a large group of patients' sera, the anti-colon reaction 
could be significantly inhibited by means of absorption with E. coli O14,  and 
the same was true in a few cases in the reverse system. The results do not imply 
that cross-reacting antibodies were absent in the sera in which hemagglutina- 
fion was not inhibited. The absorption procedure used in the screening tests of 
Table III was rather crude, and hemagglufinafion would probably have been 
inhibited in a larger proportion of the sera by using more sensitive tests and 
more highly purified antigen preparations. Furthermore, the spectrum of anti- 
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siderable  variations in individual sera  (11). Hemagglutination titers are de- 
terlnined  by  the  antibodies  present  in  highest  concentration.  Moreover, 
differences in concentration of active determinants or of their availability in 
different extracts will affect the outcome of both the hemagglutination and the 
hemagglutination inhibition tests. Further analysis requires greater knowledge 
of the iminunochemistry  of the antigens and of the specificity of the antibodies 
in individual sera. 
Examination of a few selected sera for cross-reactivity with several bacterial 
antigens by means of a more sensitive hemagglutination inhibition technique 
indicated that E. coli 014 was the single potent inhibitor, only about 10 times 
less active on a weight basis than the colon extract. A few of the other E. coli 
strains inhibited weakly probably because of a somewhat elevated concentra- 
tion of the heterogenetic antigen (see below).  Since  the strains tested were 
devoid of blood group activity (A and H), no such cross-reactions were involved. 
It is of considerable interest that anti-colon antibodies induced in rats by im- 
munization with newborn rabbit colon have an identical pattern of reactivity 
in hemagglutination inhibition tests (11). 
Although the  data  described  above  show  beyond reasonable  doubt  that 
colon extract and E. coli O14 contain common structures reactive with anti- 
bodies in ulcerative colitis sera, they do not prove that the antigen involved is 
the common antigen of the Enterobacteriaceae. Evidence for this was obtained 
in hemagglutination inhibition experiments,  in which  the  reaction between 
rabbit antisera to E. coli O14 and E. coli O8 sensitized sheep erythrocytes was 
inhibited with colon-extract, while no inhibition was usually encountered when 
erythrocytes  were sensitized with E. coli 014. These experiments also suggested 
that the concentration (or activity) of the common antigen varied in extracts 
of different E. coli strains. 
Asherson and Holborow (25) have previously shown that the serum of rabbits 
injected with  some  E.  coli  or  related bacteria develop  colon-reactive  anti- 
bodies, demonstrable by the fluorescent  antibody test. This staining may, in 
fact, also have been caused by antibodies to the heterogenetic antigen (26). 
The data presented here suggested  that anticolon antibody production in 
ulcerative colitis may be initiated by stimulation with a cross-reacting bacterial 
antigen.  However,  if  this  ubiquitous  antigen  of  F.nterobacteriaceae  is  the 
responsible antigen, it is obvious that additional factors must account for the 
occurrence  of elevated autoantibodies to colon in this disease. It is possible 
that a genetic predisposition  may play a role, since preliminary data indicate 
that relatives of ulcerative colitis patients have a higher incidence of anticolon 
antibodies than is found in the normal population (unpublished  observations). 
The data do not reveal the nature of the genetic lesions which may be involved. 
These may be entirely nonimmunologlcal  (1). Whether or not  autoimmunity 
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largely unknown, although there are some data in support of potentially harm- 
ful immunological mechanisms in this disease (27-29). 
SUMMARY 
The incidence and height of antibody titers to colon,  assayed by indirect 
hemagglutination with a heat stable colon extract from germ free rats, is signif- 
icantly higher in sera from patients with ulcerative colitis than in those from 
healthy controls or from patients with amebic  liver  abscess  or  dysentery. 
While sera from ulcerative colitis patients and controls are indistinguishable in 
regard to incidence and height of antibody titers to Forsman antigen, Stapkylo- 
coccus  aureus  S  209,  Clostridium  diff~ile,  and several common strains of E. 
coli,  they have elevated titers and increased incidence of antibodies to a  heat 
stable antigen of E.  coli O14.  Patients with amebic  dysentery have normal 
titers of such antibodies. 
Absorption  of patients'  sera  with E.  coli  O14  antigen inhibits  the  colon 
directed hemagglutination reaction in approximately 30 % of the cases tested. 
Likewise, the anti-E, coli O14  reaction can sometimes be inhibited with the 
colon extract. Other E. coli strains and other bacteria are inactive or have only 
weak inhibitory activity. Hemagglutination inhibition experiments show that 
germ free rat colon and E.  coli O14  contain common structures, depicted by 
antibodies in the patients' sera. This pattern  of reactivity closely resembles 
that seen in rats made autoimmune to colon by injection of newborn rabbit 
colon. 
E. coli O14 is known to carry a heterogenetic antigen present in lower con- 
centration (or activity) in most Enterobacteriaceae. Hemagglutination inhibi- 
tion experiments with rabbit antisera to E. coli O14  suggest that the antigen 
common for E. coli O14 and colon is related to this heterogenetic antigen. The 
findings imply that this antigen, which is constantly present in low concentra- 
tions in the human colon, may give rise to anticolon antibody formation in 
ulcerative colitis through breakage of tolerance. Since this antigen is present in 
healthy individuals as well, additional factors are required to explain the induc- 
tion of anti-colon autoimmunity in ulcerative colitis. 
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